Practice-changing trials for metastatic breast cancer, a promising antibody-drug conjugate for early-stage breast cancer, and more updates from SABCS

More progress needs to be made to improve outcomes for Black women with breast cancer. Here’s how BCRF investigators are addressing the challenge.

On World Cancer Day, BCRF reflects on the Foundation's international impact and our global efforts to end breast cancer.

BCRF explores the links between exercise and breast cancer risk and what the latest research shows.

What you need to know about how diet and breast cancer are linked, including what to eat to reduce your risk and what to avoid

Learn how BCRF support helped Dr. Olivera Finn at and her team at the University of Pittsburgh launch a trial for a vaccine to prevent breast cancer.

Dr. Sarat Chandarlapaty uncovered a novel strategy to overcome resistance and extend the utility of CDK4/6 inhibitors in patients with metastatic ER-positive breast cancer.

This Breast Cancer Awareness Month, BCRF will host the 40-Mile Move Challenge, a free virtual fitness event on Facebook that raises funds for lifesaving research.

New research reveals breast cancer rates are increasing faster among younger women than any other group. Elaine Quijano reports on the findings.

What you need to know about how diet and breast cancer are linked, including what to eat to reduce your risk and what to avoid

What to know about how alcohol and breast cancer risk are connected, including the latest research and recommendations.

BCRF investigators and others shared notable updates on potential new breast cancer treatments, clinical trials, and much more

Dana-Farber researchers pursue innovative strategies in nutrition, fitness, and scientific research to lower the risk of obesity-related cancers.

Dr. Vonderheide explores how boosting our body’s natural defenses could lead to new ways to prevent, treat, and even cure breast cancer There are many remarkable ways that scientists globally seek to ...

Investigators at SABCS 2024 reported important early findings from the BCRF-supported COMET trial studying active monitoring as treatment for DCIS.